AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 13,100
-400 (-2.96%)
At close: Oct 22, 2026
AprilBio Market Cap
AprilBio has a market cap or net worth of 360.37 billion as of October 22, 2026. It is the 18,649th most valuable company in the world and the 557th biggest in South Korea. Its market cap has decreased by 49.98% in one year.
Market Cap
360.37B
Enterprise Value
280.18B
Revenue
725.35M
Global Rank
Country Rank
#557 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 28, 2022, AprilBio's market cap has increased from 229.75B to 360.37B, an increase of 56.86%. That is a compound annual growth rate of 11.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 360.37B | -71.72% |
| Dec 30, 2025 | 1.27T | 250.56% |
| Dec 30, 2024 | 363.46B | -0.02% |
| Dec 28, 2023 | 363.53B | 96.13% |
| Dec 29, 2022 | 185.35B | -19.33% |
| Jul 28, 2022 | 229.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rznomics | 652.10B |
| JS Link | 646.40B |
| ROKIT Healthcare | 369.86B |
| Curocell | 366.21B |
| Inventage Lab | 334.02B |
| HansBiomed | 270.97B |
| S.Biomedics | 266.28B |
| IntoCell | 254.77B |